Glaxo heart drug that failed trial shows potential benefit

[riky]

Glaxo heart drug that failed trial shows potential benefit

<p><a href="http://news.yahoo.com/study-shows-glaxo-heart-drug-failed-trial-potential-130117464--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/C.b5DLJCuQh98tIYHyOp3g--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-03-30T130117Z_1_CBREA2T106T00_RTROPTP_2_LUXEMBOURG.JPG" width="130" height="86" alt="The GlaxoSmithKline logo is seen at the entrance of a building in Luxembourg" align="left" title="The GlaxoSmithKline logo is seen at the entrance of a building in Luxembourg" border="0" /></a>By Bill Berkrot and Ransdell Pierson WASHINGTON (Reuters) - A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of potential benefit, the trial's co-leader said. &quot;I'm convinced there is a signal here of efficacy and the drug is safe,&quot; said Dr. Harvey White, co-chair of the large, Glaxo-sponsored international study, who presented the findings. The real test of darapladib is likely to come from a second, late-stage study in far less stable patients who received the medicine within 30 days of a heart attack. Glaxo had previously said darapladib did no better than a placebo in decreasing the risk of a combination of cardiovascular death, heart attack and stroke in the trial called Stability.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login